Complete Filing Data
Werewolf Therapeutics, Inc. reported Stockholders Equity of $24.81 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Werewolf Therapeutics, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income Loss | -$60.8M | -$70.5M | -$37.4M | -$53.8M | -$50.0M | -$15.0M |
| Research And Development Expense | $44.8M | $56.4M | $41.8M | $53.8M | $35.3M | $16.6M |
| Operating Income Loss | -$60.7M | -$73.6M | -$40.5M | -$56.1M | -$50.1M | -$22.4M |
| Operating Expenses | $60.7M | $75.5M | $60.4M | $72.5M | $50.1M | $22.4M |
| Nonoperating Income Expense | -$145.0K | $3.1M | $3.1M | $2.2M | $104.0K | $7.4M |
| General And Administrative Expense | $15.8M | $19.0M | $18.7M | $18.7M | $14.8M | $5.8M |
| Other Nonoperating Income Expense | $2.0M | $1.6M | -$1.1M | $338.0K | ||
| Revenue From Collaborative Arrangement Excluding Revenue From Contract With Customer | $0.00 | $1.9M | $19.9M | $16.4M | $0.00 | |
| Non Cash Interest Expense | $2.1M | $1.3M | $273.0K | $0.00 | ||
| Net Income Loss Available To Common Stockholders Diluted | -$53.8M | -$201.9M | -$28.2M | |||
| Net Income Loss Available To Common Stockholders Basic | -$53.8M | -$201.9M | -$28.2M | |||
| Interest Expense Nonoperating | $5.3M | $4.7M | $3.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | -$16.4M | -$18.0M | -$18.1M | -$16.7M | -$17.2M | -$16.2M | -$8.3M | -$5.1M | -$12.0M | -$11.9M | -$14.6M | -$15.3M | -$13.8M | -$10.9M | -$7.4M | -$6.1M | $2.3M | -$3.8M |
| Research And Development Expense | $11.6M | $13.1M | $13.1M | $12.5M | $15.3M | $12.9M | $10.8M | $9.6M | $11.7M | $13.1M | $13.9M | $10.9M | $9.8M | $7.3M | $4.8M | $4.8M | $3.8M | $2.8M |
| Operating Income Loss | -$15.7M | -$17.5M | -$18.0M | -$17.1M | -$19.0M | -$17.2M | -$9.3M | -$6.1M | -$12.2M | -$12.5M | -$15.0M | -$15.4M | -$13.8M | -$11.0M | -$7.5M | -$6.1M | -$5.1M | -$3.9M |
| Operating Expenses | $15.7M | $17.5M | $18.0M | $17.1M | $20.1M | $17.9M | $15.1M | $14.1M | $16.7M | $17.5M | $19.1M | $15.4M | $13.8M | $11.0M | $7.5M | $6.1M | $5.1M | $3.9M |
| Nonoperating Income Expense | -$644.0K | -$440.0K | -$98.0K | $451.0K | $1.7M | $969.0K | $966.0K | $969.0K | $241.0K | $596.0K | $378.0K | $23.0K | $37.0K | $35.0K | $17.0K | -$15.0K | $7.3M | $67.0K |
| General And Administrative Expense | $4.1M | $4.4M | $4.9M | $4.6M | $4.8M | $5.0M | $4.3M | $4.6M | $5.0M | $4.4M | $5.2M | $4.4M | $4.0M | $3.7M | $2.6M | $1.2M | $1.3M | $1.1M |
| Other Nonoperating Income Expense | $0.00 | $11.0K | $168.0K | $97.0K | $1.6M | -$1.0K | -$5.0K | -$25.0K | -$1.1M | $3.0K | $281.0K | -$16.0K | -$17.0K | -$16.0K | -$16.0K | -$3.0K | $0.00 | |
| Revenue From Collaborative Arrangement Excluding Revenue From Contract With Customer | $0.00 | $0.00 | $0.00 | $0.00 | $1.1M | $742.0K | $5.9M | $8.1M | $4.5M | $5.0M | $4.1M | $0.00 | $0.00 | $0.00 | ||||
| Non Cash Interest Expense | $490.0K | $92.0K | $13.0K | $0.00 | ||||||||||||||
| Net Income Loss Available To Common Stockholders Diluted | -$11.9M | -$14.6M | -$15.3M | -$13.8M | -$67.8M | -$102.5M | -$6.1M | $2.2M | -$3.8M | |||||||||
| Net Income Loss Available To Common Stockholders Basic | -$11.9M | -$14.6M | -$15.3M | -$13.8M | -$67.8M | -$102.5M | -$6.1M | $2.2M | -$3.8M | |||||||||
| Interest Expense Nonoperating | $1.3M | $1.3M | $1.3M | $1.2M | $1.1M | $1.0M | $1.0M | $955.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | $24.8M | $73.4M | $111.4M | $122.3M | $152.8M | -$51.9M | -$24.3M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $58.0M | $112.2M | $155.6M | $130.5M | $158.8M | $92.8M | $18.1M |
| Cash And Cash Equivalents At Carrying Value | $57.1M | $111.0M | $134.3M | $129.3M | $92.6M | ||
| Restricted Cash Noncurrent | $901.0K | $1.2M | $21.0M | $1.2M | $207.0K | ||
| Retained Earnings Accumulated Deficit | -$475.4M | -$414.6M | -$344.1M | -$306.7M | -$252.9M | -$51.9M | |
| Property Plant And Equipment Net | $4.7M | $6.3M | $8.0M | $9.0M | $2.9M | $651.0K | |
| Prepaid Expense And Other Assets Current | $1.5M | $2.1M | $2.7M | $4.0M | $3.5M | $344.0K | |
| Operating Lease Right Of Use Asset Amortization Expense | $785.0K | $887.0K | $1.6M | $1.4M | $519.0K | $627.0K | |
| Operating Lease Right Of Use Asset | $5.2M | $6.0M | $6.9M | $8.5M | $13.4M | $2.5M | |
| Operating Lease Liability Noncurrent | $7.7M | $9.4M | $11.0M | $12.6M | $14.6M | $1.9M | |
| Operating Lease Liability Current | $1.8M | $1.6M | $1.6M | $2.1M | $1.1M | $677.0K | |
| Liabilities Current | $36.1M | $15.2M | $19.4M | $24.0M | $11.9M | $5.3M | |
| Liabilities And Stockholders Equity | $69.4M | $126.9M | $174.8M | $160.2M | $179.3M | $96.4M | |
| Liabilities | $44.6M | $53.5M | $63.5M | $37.9M | $26.5M | $7.2M | |
| Common Stock Value | $5.0K | $5.0K | $4.0K | $3.0K | $2.0K | $2.0K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$54.3M | -$43.4M | $25.0M | -$28.3M | $66.1M | $74.7M | |
| Assets Current | $58.6M | $113.1M | $138.4M | $140.2M | $161.1M | $92.9M | |
| Assets | $69.4M | $126.9M | $174.8M | $160.2M | $179.3M | $96.4M | |
| Accrued Liabilities Current | $5.4M | $10.6M | $8.9M | $14.2M | $8.8M | $3.6M | |
| Accounts Payable Current | $754.0K | $3.0M | $1.3M | $1.2M | $2.0M | $1.0M | |
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Other Assets Noncurrent | $5.0K | $320.0K | $594.0K | $1.4M | $649.0K | $0.00 | |
| Temporary Equity Accretion To Redemption Value Adjustment | $0.00 | $151.9M | $13.2M | ||||
| Long Term Notes Payable | $0.00 | $26.1M | $32.7M | $0.00 | |||
| Other Receivables Net Current | $0.00 | $1.4M | $6.9M | $0.00 | |||
| Other Liabilities Noncurrent | $0.00 | $191.0K | $0.00 | $31.0K | |||
| Contract With Customer Liability Noncurrent | $0.00 | $433.0K | $1.1M | $0.00 | |||
| Gains Losses On Extinguishment Of Debt | $0.00 | -$553.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $29.6M | $41.5M | $57.3M | $89.4M | $104.0M | $117.6M | $112.4M | $118.6M | $121.1M | $130.9M | $129.8M | $139.3M | $169.3M | $181.6M | -$153.8M | -$31.6M | -$25.6M | -$28.1M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $66.6M | $78.5M | $93.3M | $124.0M | $136.5M | $160.4M | $151.3M | $158.7M | $169.1M | $141.7M | $147.0M | $145.0M | $171.7M | $184.5M | $84.9M | $26.9M | $32.0M | $14.3M | |
| Cash And Cash Equivalents At Carrying Value | $65.7M | $77.6M | $92.0M | $122.8M | $135.3M | $139.2M | $130.1M | $137.5M | $147.9M | $140.5M | $145.7M | $143.7M | $157.5M | $170.4M | $183.2M | $84.6M | |||
| Restricted Cash Noncurrent | $898.0K | $895.0K | $891.0K | $1.2M | $1.2M | $21.0M | $21.0M | $21.0M | $21.0M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $298.0K | |||
| Retained Earnings Accumulated Deficit | -$467.0M | -$450.7M | -$432.7M | -$394.2M | -$377.5M | -$360.3M | -$332.1M | -$323.8M | -$318.7M | -$294.8M | -$282.8M | -$268.2M | -$235.0M | -$221.3M | -$153.8M | ||||
| Property Plant And Equipment Net | $5.1M | $5.5M | $5.9M | $6.8M | $7.1M | $7.5M | $8.3M | $8.4M | $8.7M | $9.2M | $9.0M | $6.1M | $789.0K | $689.0K | $694.0K | ||||
| Prepaid Expense And Other Assets Current | $2.5M | $2.8M | $2.4M | $2.5M | $2.9M | $2.3M | $3.3M | $3.0M | $2.4M | $6.8M | $6.2M | $1.7M | $4.0M | $3.1M | $263.0K | ||||
| Operating Lease Right Of Use Asset Amortization Expense | $188.0K | $376.0K | $336.0K | $383.0K | $166.0K | $152.0K | |||||||||||||
| Operating Lease Right Of Use Asset | $5.4M | $5.6M | $5.8M | $6.2M | $6.3M | $6.5M | $7.3M | $7.8M | $8.1M | $8.6M | $9.1M | $11.2M | $2.0M | $2.1M | $2.3M | ||||
| Operating Lease Liability Noncurrent | $8.1M | $8.6M | $9.0M | $9.8M | $10.2M | $10.6M | $11.4M | $11.7M | $12.0M | $13.1M | $13.7M | $14.3M | $1.3M | $1.5M | $1.7M | ||||
| Operating Lease Liability Current | $1.5M | $1.5M | $1.4M | $1.3M | $1.3M | $1.2M | $1.6M | $2.0M | $2.1M | $2.0M | $1.9M | $1.5M | $744.0K | $721.0K | $699.0K | ||||
| Liabilities Current | $17.6M | $15.2M | $11.7M | $12.5M | $11.4M | $21.2M | $14.4M | $15.0M | $21.7M | $27.8M | $30.4M | $11.0M | $7.8M | $7.4M | $5.4M | ||||
| Liabilities And Stockholders Equity | $79.6M | $92.6M | $107.2M | $140.0M | $153.7M | $177.6M | $176.4M | $185.2M | $195.1M | $172.4M | $175.3M | $164.6M | $178.4M | $190.4M | $89.4M | ||||
| Liabilities | $50.0M | $51.1M | $49.9M | $50.7M | $49.7M | $60.0M | $63.9M | $66.6M | $74.0M | $41.5M | $45.5M | $25.3M | $9.1M | $8.9M | $7.1M | ||||
| Common Stock Value | $5.0K | $5.0K | $5.0K | $4.0K | $4.0K | $4.0K | $3.0K | $3.0K | $3.0K | $3.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$18.9M | $4.9M | $38.6M | -$13.8M | -$7.9M | -$3.8M | |||||||||||||
| Assets Current | $68.2M | $80.4M | $94.5M | $125.8M | $138.8M | $142.3M | $139.3M | $147.4M | $156.6M | $151.6M | $154.2M | $145.4M | $174.4M | $186.4M | $84.9M | ||||
| Assets | $79.6M | $92.6M | $107.2M | $140.0M | $153.7M | $177.6M | $176.4M | $185.2M | $195.1M | $172.4M | $175.3M | $164.6M | $178.4M | $190.4M | $89.4M | ||||
| Accrued Liabilities Current | $9.0M | $8.5M | $9.3M | $9.9M | $8.7M | $6.2M | $8.0M | $9.9M | $13.3M | $13.9M | $14.1M | $8.2M | $5.6M | $3.5M | $2.9M | ||||
| Accounts Payable Current | $1.1M | $2.8M | $986.0K | $1.2M | $1.5M | $1.6M | $1.4M | $1.5M | $2.1M | $1.4M | $2.6M | $1.4M | $1.5M | $3.2M | $1.8M | ||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| Other Assets Noncurrent | $46.0K | $122.0K | $179.0K | $42.0K | $265.0K | $248.0K | $516.0K | $652.0K | $670.0K | $1.9M | $1.9M | $642.0K | |||||||
| Temporary Equity Accretion To Redemption Value Adjustment | $0.00 | $0.00 | $0.00 | $0.00 | $56.9M | $95.0M | $0.00 | $31.0K | $0.00 | ||||||||||
| Long Term Notes Payable | $21.7M | $24.7M | $26.6M | $25.6M | $25.2M | $27.7M | $37.6M | $39.1M | $39.1M | ||||||||||
| Other Receivables Net Current | $464.0K | $545.0K | $775.0K | $5.9M | $6.9M | $6.3M | $4.3M | $2.2M | |||||||||||
| Other Liabilities Noncurrent | $0.00 | $0.00 | $0.00 | $191.0K | $191.0K | $0.00 | $0.00 | $0.00 | |||||||||||
| Contract With Customer Liability Noncurrent | $0.00 | $0.00 | $431.0K | $588.0K | $783.0K | $1.2M | $343.0K | $1.3M | |||||||||||
| Gains Losses On Extinguishment Of Debt | $0.00 | $0.00 | $0.00 | -$553.0K | $0.00 | $0.00 |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Share Based Compensation | $6.2M | $8.8M | $8.0M | $7.4M | $4.1M | $632.0K |
| Proceeds From Stock Options Exercised | $0.00 | $35.0K | $7.0K | $254.0K | $205.0K | $26.0K |
| Payments To Acquire Property Plant And Equipment | $0.00 | $254.0K | $769.0K | $3.6M | $498.0K | $560.0K |
| Net Cash Provided By Used In Operating Activities | -$60.3M | -$56.2M | -$32.6M | -$40.6M | -$42.9M | -$18.6M |
| Net Cash Provided By Used In Investing Activities | $0.00 | -$254.0K | -$769.0K | -$3.6M | -$498.0K | -$560.0K |
| Net Cash Provided By Used In Financing Activities | $6.0M | $13.1M | $58.4M | $15.9M | $109.4M | $93.9M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$850.0K | -$669.0K | -$1.3M | $262.0K | $3.1M | $177.0K |
| Proceeds From Issuance Of Common Stock | $5.9M | $23.6M | $18.3M | $15.7M | $0.00 | |
| Increase Decrease In Other Receivables | $0.00 | -$1.4M | -$5.6M | $6.9M | $0.00 | |
| Increase Decrease In Contract With Customer Liability | $0.00 | -$1.3M | -$6.3M | $7.7M | $0.00 | |
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $6.2M | $8.8M | $8.0M | $7.4M | ||
| Increase Decrease In Other Operating Liabilities | $191.0K | -$31.0K | $8.0K | |||
| Increase Decrease In Operating Lease Liability | -$1.6M | -$1.6M | -$2.1M | -$977.0K | ||
| Increase Decrease In Accrued Liabilities | $3.7M | $5.3M | $2.6M | |||
| Increase Decrease In Accounts Payable Trade | -$883.0K | $1.0M | $388.0K | |||
| Proceeds From Stock Plans | $89.0K | $142.0K | $93.0K | $0.00 | ||
| Proceeds From Issuance Of Debt | $0.00 | $30.0M | $40.0M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $2.0M | $2.3M | $2.1M | $1.7M | $539.0K | $57.0K | ||||||
| Proceeds From Stock Options Exercised | $0.00 | $12.0K | $0.00 | $159.0K | $21.0K | $0.00 | ||||||
| Payments To Acquire Property Plant And Equipment | $0.00 | $111.0K | $168.0K | $28.0K | $13.0K | $449.0K | ||||||
| Net Cash Provided By Used In Operating Activities | -$18.9M | -$15.3M | -$9.9M | -$14.0M | -$7.3M | -$3.4M | ||||||
| Net Cash Provided By Used In Investing Activities | $0.00 | -$111.0K | -$168.0K | -$28.0K | -$13.0K | -$449.0K | ||||||
| Net Cash Provided By Used In Financing Activities | $0.00 | $20.3M | $48.6M | $159.0K | -$538.0K | $0.00 | ||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$131.0K | -$704.0K | -$1.4M | -$1.8M | -$81.0K | -$23.0K | ||||||
| Proceeds From Issuance Of Common Stock | $0.00 | $20.2M | $8.6M | $0.00 | ||||||||
| Increase Decrease In Other Receivables | $0.00 | -$575.0K | -$673.0K | $0.00 | ||||||||
| Increase Decrease In Contract With Customer Liability | $0.00 | -$407.0K | -$2.3M | $0.00 | ||||||||
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $1.2M | $1.8M | $2.0M | $2.0M | $2.6M | $2.3M | $2.1M | $1.9M | $2.1M | |||
| Increase Decrease In Other Operating Liabilities | -$191.0K | $0.00 | $50.0K | -$11.0K | ||||||||
| Increase Decrease In Operating Lease Liability | -$563.0K | -$744.0K | -$495.0K | -$159.0K | -$71.0K | |||||||
| Increase Decrease In Accrued Liabilities | $133.0K | -$2.0M | -$1.3M | -$47.0K | ||||||||
| Increase Decrease In Accounts Payable Trade | $961.0K | -$674.0K | $724.0K | $302.0K | ||||||||
| Proceeds From Stock Plans | ||||||||||||
| Proceeds From Issuance Of Debt | $0.00 | $40.0M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 46.0M | 43.3M | 35.6M | 28.9M | 18.5M | 1.0M |
| Weighted Average Number Of Diluted Shares Outstanding | 46.8M | 43.9M | 35.6M | 28.9M | 18.5M | 1.0M |
| Earnings Per Share Diluted | $-1.33 | $-1.63 | $-1.05 | $-1.86 | $-10.94 | $-28.08 |
| Earnings Per Share Basic | $-1.32 | $-1.63 | $-1.05 | $-1.86 | $-10.94 | $-28.08 |
| Common Stock Shares Outstanding | 48.6M | 44.8M | 39.1M | 31.4M | 27.3M | 1.2M |
| Common Stock Shares Issued | 48.6M | 44.8M | 39.1M | 31.5M | 27.6M | 1.7M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 193.5M |
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 45.8M | 45.0M | 44.8M | 43.7M | 43.5M | 41.6M | 35.7M | 35.6M | 34.8M | 29.8M | 27.5M | 27.4M | 27.2M | 17.8M | 1.2M | 918.0K | 947.0K | 836.0K |
| Weighted Average Number Of Diluted Shares Outstanding | 45.8M | 45.0M | 44.8M | 43.7M | 44.0M | 41.6M | 35.7M | 35.6M | 34.8M | 29.8M | 27.5M | 27.4M | 27.2M | 17.8M | 1.2M | 918.0K | 10.3M | 836.0K |
| Earnings Per Share Diluted | $-0.36 | $-0.40 | $-0.40 | $-0.38 | $-0.43 | $-0.39 | $-0.23 | $-0.14 | $-0.34 | $-0.40 | $-0.53 | $-0.56 | $-0.51 | $-3.82 | $-83.36 | $-6.61 | $0.22 | $-4.58 |
| Earnings Per Share Basic | $-0.36 | $-0.40 | $-0.40 | $-0.38 | $-0.40 | $-0.39 | $-0.23 | $-0.14 | $-0.34 | $-0.40 | $-0.53 | $-0.56 | $-0.51 | $-3.82 | $-83.36 | $-6.61 | $2.35 | $-4.58 |
| Common Stock Shares Outstanding | 47.3M | 45.3M | 44.8M | 43.7M | 43.7M | 43.3M | 35.7M | 35.6M | 35.3M | 30.6M | 28.3M | 27.4M | 27.2M | 27.1M | 1.8M | |||
| Common Stock Shares Issued | 47.3M | 45.3M | 44.8M | 43.7M | 43.7M | 43.3M | 35.7M | 35.6M | 35.3M | 30.7M | 28.5M | 27.7M | 27.6M | 27.6M | 1.8M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 196.0M | |||
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Stock Issued During Period Value Stock Options Exercised | $35.0K | $7.0K | $224.0K | $235.0K | $26.0K | |
| Stock Issuance Costs Incurred But Not Yet Paid | $120.0K | $84.0K | $36.0K | $4.0K | $0.00 | $154.0K |
| Depreciation | $1.6M | $1.8M | $1.8M | $1.1M | $216.0K | $150.0K |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $7.4M | $4.1M | $632.0K | |||
| Additional Paid In Capital | $500.2M | $488.0M | $455.4M | $429.0M | $405.7M | $0.00 |
| Investment Income Net | $1.9M | $104.0K | $63.0K | |||
| Capital Expenditures Incurred But Not Yet Paid | $0.00 | $76.0K | $111.0K | $79.0K | $0.00 | |
| Stock Issued During Period Value New Issues | $89.0K | $142.0K | $93.0K | $15.7M | $109.2M | |
| Investment Income Interest | $3.1M | $6.7M | $7.4M | $1.9M | ||
| Interest Paid Net | $3.1M | $3.4M | $2.6M | $0.00 | ||
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | $455.0K | $2.4M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Issued During Period Value Stock Options Exercised | $23.0K | $0.00 | $12.0K | $2.0K | $5.0K | $93.0K | $1.0K | $129.0K | $26.0K | $131.0K | $21.0K | $4.0K | ||||||
| Stock Issuance Costs Incurred But Not Yet Paid | $0.00 | $194.0K | $17.0K | $0.00 | $560.0K | $0.00 | ||||||||||||
| Depreciation | $426.0K | $464.0K | $425.0K | $98.0K | $39.0K | $23.0K | ||||||||||||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $2.1M | $1.9M | $2.1M | $1.9M | $1.8M | $1.7M | $1.5M | $781.0K | $539.0K | $133.0K | $221.0K | $57.0K | ||||||
| Additional Paid In Capital | $496.6M | $492.1M | $490.0M | $483.6M | $481.5M | $477.8M | $444.5M | $442.4M | $439.8M | $425.7M | $412.7M | $407.6M | $404.3M | $402.8M | $0.00 | |||
| Investment Income Net | $971.0K | $994.0K | $1.3M | $593.0K | $97.0K | $39.0K | $54.0K | $51.0K | $17.0K | -$15.0K | $24.0K | $67.0K | ||||||
| Capital Expenditures Incurred But Not Yet Paid | $0.00 | $79.0K | $1.6M | $130.0K | $66.0K | |||||||||||||
| Stock Issued During Period Value New Issues | $41.0K | $76.0K | $30.0K | $45.0K | $8.6M | $11.0M | $3.3M | $109.2M | ||||||||||
| Investment Income Interest | $697.0K | $850.0K | $997.0K | $1.6M | $1.8M | $2.0M | $2.0M | $1.9M | $1.5M | |||||||||
| Interest Paid Net | $773.0K | $910.0K | $0.00 | |||||||||||||||
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | $29.0K | $31.0K | $103.0K | $87.0K | $314.0K | $2.4M | $2.4M | $31.0K |
Most recent annual filing with the SEC: March 27, 2026
Data sourced from SEC EDGAR public filings as of August 7, 2026.